Vimarsana
Biggest News Aggregation in the World

Page 9 - Ivan Cheung News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ivan Cheung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ivan Cheung Today - Breaking & Trending Today

Eisai and Biogen Alzheimer's drug lecanemab receives approval from FDA - Vimarsana News

Eisai and Biogen Alzheimer's drug lecanemab receives approval from FDA

Eisai and Biogen's drug, sold under the brand name Leqembi, is the first amyloid-targeting medication to pass the FDA's full review.

First Alzheimer's drug to slow disease progression expected to get full FDA approval - Vimarsana News

First Alzheimer's drug to slow disease progression expected to get full FDA approval

CBS 58 is your local source for the Milwaukee news, Milwaukee weather, and Milwaukee sports.

Source: cbs58.com
US FDA grants standard approval of Eisai/Biogen Alzheimer's drug - Vimarsana News

US FDA grants standard approval of Eisai/Biogen Alzheimer's drug

LOS ANGELES (Reuters) -Eisai and Biogen's Leqembi won a coveted standard approval nod from the U.S. Food and Drug Administration on Thursday, the first Alzheimer's treatment to achieve that goal, clearing the way for wider insurance coverage of the drug. The FDA decision marks a new milestone for a fatal disease that has eluded drugmakers' efforts for decades. Trial data showed that the treatment slows progression of the brain-wasting disease by 27% for patients in the earliest stages of Alzheimer's.

Source: yahoo.com
Eisai and Biogen Alzheimer's drug lecanemab receives approval from FDA - Vimarsana News

Eisai and Biogen Alzheimer's drug lecanemab receives approval from FDA

Eisai and Biogen's drug, sold under the brand name Leqembi, is the first amyloid-targeting medication to pass the FDA's full review.

US FDA grants standard approval of Eisai/Biogen Alzheimer's drug - Vimarsana News

US FDA grants standard approval of Eisai/Biogen Alzheimer's drug

A new milestone for a fatal disease that has eluded drugmakers' efforts for decades.